The state’s ongoing efforts to lure businesses to New Jersey hit the road to Chicago this week, to attend the BIO International Convention, an event that drew more than 16,500 industry leaders from 65 countries last year.
Choose New Jersey is leading a delegation that includes Lt. Gov. Kim Guadagno, the Business Action Center, BioNJ, the HealthCare Institute of New Jersey, and several universities and health care companies to showcase New Jersey as one of the world’s premiere locations for life science companies and medical research. Representatives from the state will meet with life science companies that could be prospects for moving or expanding to New Jersey.
“New Jersey offers unrivaled opportunities for pharmaceutical, biotechnology and medical device businesses,” Guadagno said in a statement. “BIO International is the perfect forum for sharing our state’s competitive advantages with this highly targeted international audience. Simply put, our goal is to attract the businesses that will help sustain and grow the $58 billion economic output that the biopharmaceutical sector already contributes to the Garden State.”
Tracye McDaniel, president and CEO of Choose New Jersey, said the state is already home to 14 of the 20 largest biopharmaceutical companies, as well as more than 3,100 biotechnology and pharmaceutical companies, and has a thriving medical technology industry. But she would love to attract even more of that business to the state.
“With more scientists and engineers per square mile than anywhere else on the planet, three medical schools among our 63 colleges and universities, and 13 teaching hospitals, we offer biopharmaceutical companies a ‘brain belt’ second to none,” she said.
The organizations will be at the conference’s New Jersey pavilion, which will feature the slogan “Big Ideas Happen Here.” The event runs through Thursday.